←Back to Expert Scholars
Translational Medicine / 转化医学Interferon Signaling, Tumor Immunology
Taha Merghoub
PhD
🏢Weill Cornell Medicine🌐USA
Professor of Immunology in Medicine
85
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Taha Merghoub leads cancer immunotherapy research at Weill Cornell and has studied type I interferon combinations with checkpoint blockade and novel antibody strategies. His work includes Fc engineering of antibodies to enhance anti-tumor immunity. He previously co-led cancer immunotherapy research at Memorial Sloan Kettering.
Share:
🧪Research Fields 研究领域
tumor immunotherapy
type I interferon combinations
checkpoint combinations
antibody engineering
melanoma immunology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Taha Merghoub 的研究动态
Follow Taha Merghoub's research updates
留下邮箱，当我们发布与 Taha Merghoub（Weill Cornell Medicine）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment